Author:
Sonnweber Bettina,Schaber Marc,Wöll Ewald
Publisher
Springer Science and Business Media LLC
Reference36 articles.
1. Noone AM, Howlader N, Krapcho M, Miller D, Bishop K, Altekruse SF, et al. SEER cancer statistics review, 1975–2013, National Cancer Institute. Bethesda, MD, USA. 2015. http://seer.cancer.gov/csr/1975_2013/ (Created 11.2015), SEER datasubmission, posted to the SEER web site, April 2016.
2. Cunningham D, Allum WH, Stenning SP, Thompson JN, Van de Velde CJ, Nicolson M, et al. MAGIC Trial Participants. Perioperative chemotherapy versus surgery alone for resectable gastroesophageal cancer. N Engl J Med. 2006;355(1):11–20. https://doi.org/10.1056/NEJMoa055531.
3. FLOT4-AIO Investigators, Al-Batran SE, Homann N, Pauligk C, Goetze TO, Meiler J, Kasper S, et al. Perioperative chemotherapy with fluorouracil plus leucovorin, oxaliplatin, and docetaxel versus fluorouracil or capecitabine plus cisplatin and epirubicin for locally advanced, resectable gastric or gastro-oesophageal junction adenocarcinoma (FLOT4): a randomised, phase 2/3 trial. Lancet. 2019;393(10184):1948–57. https://doi.org/10.1016/S0140-6736(18)32557-1.
4. Smyth EC, Verheij M, Allum W, Cunningham D, Cervantes A, Arnold D, ESMO Guidelines Committee. Gastric cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2016;27(suppl 5):v38–v49. https://doi.org/10.1093/annonc/mdw350.
5. Wöll E, Eisterer W, Gerger A, Kühr T, Prager GW, Rumpold H, et al. Treatment algorithm for patients with gastric adenocarcinoma: an Austrian consensus on systemic therapy. Anticancer Res. 2019;39(9):4589–96. https://doi.org/10.21873/anticanres.13638.
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献